Wilson, J.T. : Phenobarbital in the perinatal period. Pediatrics43: 324, 1969.
2.
—: Phenobarbitone and the neonate. Lancet2: 214, 1969.
3.
Davies, P.A. : Phenobarbitone and dicophane in jaundice. Ibid.2: 273, 1969.
4.
Behrman, R.E. and Fisher, D.E.: Phenobarbital for neonatal jaundice . J. Pediat.76: 945, 1970.
5.
McMullin, G.P. , Hayes, M.F. and Arora, S.C.: Phenobarbitone in rhesus haemolytic disease— a controlled trial. Lancet2: 949, 1970.
6.
Kuntzman, R. : Drugs and enzyme induction. Ann. Rev. Pharmacol.9: 21, 1969.
7.
Editorial: Roots of aggression. Lancet1: 460, 1970.
8.
Mayman, C.I. , Galfield, P.D. and Breckenridge , J.: The glucose content of brain in anaesthesia. J. Neurochem.11: 483, 1964.
9.
Schultz, J. and Van Creveld, S.: Stuart-Power factor in newborn infants. Etudes Neonatales7: 133, 1958.
10.
Mountain, K.R. , Hirsh, J. and Gallus, A.S.: Neonatal coagulation defect due to anticonvulsant drug treatment in pregnancy. Lancet1: 265, 1970.
11.
Evans, A.R. , Dorrester, R.M. and Discombe, C.: Neonatal haemorrhage following maternal anticonvulsant therapy. Ibid.1: 517, 1970.
12.
Prescott, L.F. : Pharmacokinetic drug interactions. Ibid.2: 1239, 1969.
13.
Odell, G.B. : "Physiologic" hyperbilirubinemia in the neonatal period. New Eng. J. Med.277: 193, 1967.
14.
Broderson, R. and Hermann, L.S.: Intestinal reabsorption of uoconjugated bilirubin. Lancet1: 1242, 1963.
15.
Poland, R.L. and Odell, G.B.: Physiologic jaundice: the enterohepatic circulation of bilirubin. New Eng. J. Med.284: 1, 1971.
16.
Bleyer, W.A. , Au, W.Y.W., Lange, W.A. and Raisz, L.G.: Studies on the detection of adverse drug reaction in the newborn I. Fetal exposure to maternal medication. JAMA213: 2046, 1970.
17.
Stern, L., Khanna, N.N., Levy, G. and Yaffe, S.J.: Effect of phenobarbital on hyperbilirubinemia and glucuronide formation in newborns. Amer. J. Dis. Child.120: 26, 1970.
18.
Ramboer, C., Thompson, R.P.H. and Williams, R.: Controlled trials of phenobarbitone therapy in neonatal jaundice. Lancet1: 966, 1969.
19.
Boggs, T.R. and Westphal, M.C.: Mortality of exchange transfusion. Pediatrics26: 745, 1960.
20.
Weldon, V.V. and Odell, G.B.: Mortality risk of exchange transfusion . Ibid.41: 797, 1968.
21.
Behrman, R.E. and Hsia, D.Y.Y.: Summary of a symposium on phototherapy for hyperbilirubinemia. J. Pediat.75: 718, 1969.
22.
Walker, W.: Phenobarbitone in rhesus haemolytic disease. Lancet2: 1089, 1970.
23.
Klaassen, C.D. : Biliary flow after microsomal enzyme induction . J. Pharmacol. Exp. Ther.168: 218, 1969 .
24.
Odell, G.B. : Studies in kernicterus. I. The protein binding of bilirubin. J. Clin. Invest.38: 823, 1959.
25.
—, Cohen, S.N. and Kelly, P.C.: Studies in kernicterus. II. The determination of the saturation of serum albumin with bilirubin. J. Pediat.74: 214, 1969.
26.
—, Storey, G.N.B. and Rosenburg , L.A.: Studies on kernicterus: III. The saturation of serum proteins with bilirubin during neonatal life and its relationship to brain damage at five years. Ibid.76: 12, 1970.
27.
—: The distribution and toxicity of bilirubin. Pediatrics46: 16, 1970.
28.
Boggs, T.R. , Hardy, J.B. and Frasier, T.M.: Correlation of neonatal serum total bilirubin concentrations and developmental status at age eight months. J. Pediat.71: 553, 1967.
29.
Ackerman, B.D. : Phenobarbital for neonatal jaundice. Ibid.77: 916, 1970.
30.
Taylor, P.M. , Seder, H.B., Mering , J. and Watson, D.W.: Comparison of the tolerance of anesthetized adult dogs and pups to KCl infusion. Pediatrics36: 905, 1965.
31.
Levi, A.J., Gatmaitan, Z. and Arias, I.M.: Deficiency of hepatic organic anion-binding protein, impaired organic amnion uptake by liver and "physiologic" jaundice in newborn monkeys. New Eng. J. Med.283: 1136, 1970.
